We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
-25.33%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$293M
AUM Growth
+$14.4M
(+5.2%)
Cap. Flow
+$92.4M
Cap. Flow
% of AUM
31.57%
Top 10 Holdings %
Top 10 Hldgs %
46.52%
Holding
48
New
20
Increased
10
Reduced
8
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$23M |
| 2 |
Innoviva
INVA
|
+$18.2M |
| 3 |
Freshpet
FRPT
|
+$16.2M |
| 4 |
Vince Holding Corp
VNCE
|
+$12.7M |
| 5 |
SPNC
Spectranetics Corp
SPNC
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
+$30.3M |
| 2 |
Theravance Biopharma
TBPH
|
+$12.7M |
| 3 |
QLGC
QLOGIC CORP
QLGC
|
+$11.5M |
| 4 |
FTD
FTD Companies, Inc. Common Stock
FTD
|
+$8.02M |
| 5 |
Lipocine
LPCN
|
+$7.29M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.14% |
| 2 | Consumer Discretionary | 16.58% |
| 3 | Industrials | 6.18% |
| 4 | Consumer Staples | 4.02% |
| 5 | Financials | 3.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Vince Holding Corp
VNCE
$78.2M
| $5.28M | 1.8% |
+154,000
| New | +$12.7M |
|
27
Abercrombie & Fitch
ANF
$4.56B
| $5.09M | 1.74% |
240,000
-172,000
| -42% | -$3.5M |
|
|
SKUL
28
DELISTED
SKULLCANDY INC
SKUL
| $4.72M | 1.61% |
854,000
-552,000
| -39% | -$3.89M |
|
|
LEAF
29
DELISTED
Leaf Group Ltd.
LEAF
| $4.56M | 1.56% |
1,094,000
+126,000
| +13% | +$646K |
|
30
Arcos Dorados Holdings
ARCO
$1.77B
| $3.81M | 1.3% |
+1,438,954
| New | +$5.5M |
|
31
Madrigal Pharmaceuticals
MDGL
$12.4B
| $3.48M | 1.19% |
+57,143
| New | +$4.12M |
|
|
BBBY
32
Bed Bath & Beyond
BBBY
$480M
| $3.09M | 1.05% |
239,580
-354,046
| -60% | -$5.53M |
|
|
XYLO
33
DELISTED
Xylo Technologies
XYLO
| $2.7M | 0.92% |
+376
| New | +$2.5M |
|
|
CBAY
34
DELISTED
Cymabay Therapeutics
CBAY
| $1.62M | 0.55% |
+836,000
| New | +$2.28M |
|
|
CPHR
35
DELISTED
Cipher Pharmaceuticals Inc.
CPHR
| $1.11M | 0.38% |
+300,000
| New | +$2.08M |
|
36
InspireMD
NSPR
$30.9M
| $1.07M | 0.37% |
1
| – | – |
|
|
RLOC
37
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
| $641K | 0.22% |
304,000
+102,000
| +50% | +$273K |
|
38
Armata Pharmaceuticals
ARMP
$169M
| $371K | 0.13% |
+670
| New | +$612K |
|
39
Tenax Therapeutics
TENX
$408M
| $266K | 0.09% |
+3
| New | +$343K |
|
|
40
Lipocine
LPCN
$17.6M
| – | – |
-50,000
| Closed | -$7.29M |
|
|
STKL
41
DELISTED
SunOpta
STKL
| – | – |
-424,000
| Closed | -$4.55M |
|
|
42
Theravance Biopharma
TBPH
$876M
| – | – |
-974,000
| Closed | -$12.7M |
|
43
Veru
VERU
$35.5M
| – | – |
-60,000
| Closed | -$1.08M |
|
|
SPPI
44
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| – | – |
-4,436,000
| Closed | -$30.3M |
|
|
SNAK
45
DELISTED
Inventure Foods, Inc.
SNAK
| – | – |
-618,000
| Closed | -$6.27M |
|
|
QLTI
46
DELISTED
QLT Inc
QLTI
| – | – |
-660,000
| Closed | -$2.73M |
|
|
QLGC
47
DELISTED
QLOGIC CORP
QLGC
| – | – |
-812,000
| Closed | -$11.5M |
|
|
BITI
48
DELISTED
BIOTIE THERAPIES CORP SPONSORED ADR
BITI
| – | – |
-200,000
| Closed | -$3.99M |
|
Similar funds
CRC
RMDI
F
DWM
DCP
EW
AIM
O
Armistice Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Armistice Capital held 48 positions worth $293M, up 5.2% from $278M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Armistice Capital deployed $92.4M of net new capital in Q3 2015, opening 20 new positions and adding to 10 existing holdings. Its largest new stake was Pernix Therapeutics Holdings, Inc.: 480,000 shares worth $15.2M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 46% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was FTD Companies, Inc. Common Stock, an estimated $8.02M trimmed.
- Armistice Capital's largest Q3 2015 buy was Pernix Therapeutics Holdings, Inc.: 480,000 shares worth $15.2M.
- Armistice Capital added most to XENOPORT, INC. in Q3 2015, an estimated $10.9M increase.
- Armistice Capital's biggest Q3 2015 reduction was FTD Companies, Inc. Common Stock, cutting an estimated $8.02M.
- Armistice Capital fully exited Spectrum Pharmaceuticals Inc in Q3 2015, selling an estimated $30.3M.
- Armistice Capital's ten largest holdings make up 47% of its $293M portfolio in Q3 2015.
- Armistice Capital opened 20 new positions and closed 9 in Q3 2015.
- Armistice Capital's portfolio value rose 5.2% quarter-over-quarter to $293M.
Based on Armistice Capital's 13F filing for Q3 2015, filed 16 Nov 2015.